Matthew G Ewend Selected Research

Matthew G Ewend Research Topics

Disease

20	Neoplasms (Cancer) 01/2020 - 02/2002
13	Brain Neoplasms (Brain Tumor) 01/2020 - 11/2005
8	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2004
7	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 03/2009
5	Neoplasm Metastasis (Metastasis) 01/2016 - 12/2004
4	Glioma (Gliomas) 10/2018 - 02/2003
2	Hemorrhage 01/2020 - 01/2017
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2017
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 03/2018 - 04/2015
2	Necrosis 01/2017 - 04/2015
2	Epistaxis (Nosebleed) 11/2004 - 11/2003
1	Cerebrospinal Fluid Leak 01/2021
1	Residual Neoplasm 01/2020
1	Edema (Dropsy) 01/2020
1	Medulloblastoma 01/2018
1	Triple Negative Breast Neoplasms 01/2016
1	Wounds and Injuries (Trauma) 04/2015
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 01/2014
1	Critical Illness (Critically Ill) 11/2009
1	Lymphatic Metastasis 03/2009
1	Lung Neoplasms (Lung Cancer) 03/2009
1	Prostatic Neoplasms (Prostate Cancer) 10/2006
1	Empty Sella Syndrome 11/2003
1	Meningitis 11/2003
1	Ophthalmoplegia (External Ophthalmoplegia) 11/2003
1	Diabetes Insipidus 11/2003
1	Hematoma 02/2003
1	Infections 02/2003
1	Virus Diseases (Viral Diseases) 02/2003
1	Epilepsy (Aura) 02/2002
1	Weight Gain 02/2002
1	Seizures (Absence Seizure) 02/2002

Drug/Important Bio-Agent (IBA)

5	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 11/2005
4	Carmustine (FIVB)FDA Link 11/2013 - 02/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2009
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2014
2	VaccinesIBA 01/2018 - 01/2018
2	Lapatinib (GW572016)FDA Link 01/2016 - 12/2007
2	Biological ProductsIBA 03/2009 - 11/2005
2	PolymersIBA 06/2007 - 02/2002
2	Protons (Proton)IBA 10/2006 - 02/2002
1	Genetic Markers (Genetic Marker)IBA 01/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2020
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	Thymidine KinaseIBA 01/2020
1	EnzymesIBA 01/2020
1	ProdrugsIBA 01/2020
1	UNC2025IBA 10/2018
1	Glial Fibrillary Acidic ProteinIBA 10/2018
1	c-Mer Tyrosine KinaseIBA 10/2018
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 10/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2018
1	human ERBB2 proteinIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2017
1	Hormones (Hormone)IBA 01/2016
1	Ado-Trastuzumab EmtansineIBA 01/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2011
1	AcidsIBA 03/2009
1	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 11/2005
1	NF-kappa B (NF-kB)IBA 02/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2003
1	NF-KappaB Inhibitor alphaIBA 02/2003
1	Carboplatin (JM8)FDA LinkGeneric 02/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2003
1	Phenytoin (Dilantin)FDA LinkGeneric 02/2002
1	Anticonvulsants (Antiepileptic Drugs)IBA 02/2002
1	Pharmaceutical PreparationsIBA 02/2002
1	ethyleneIBA 02/2002
1	CobaltIBA 02/2002
1	cobaltous chloride (cobalt(II)chloride)IBA 02/2002
1	vinyl acetateIBA 02/2002

Therapy/Procedure

11	Therapeutics 01/2020 - 02/2003
10	Radiotherapy 01/2018 - 02/2002
5	Drug Therapy (Chemotherapy) 01/2016 - 02/2003
3	Craniotomy 01/2020 - 02/2003
2	Auditory Brain Stem Implants (Auditory Brainstem Implants) 03/2018 - 04/2015
2	Length of Stay 07/2004 - 11/2003
1	Tracheostomy 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Immunotherapy 01/2017
1	Cautery 04/2015
1	Electrocoagulation (Electrocautery) 04/2015
1	Catheters 01/2014
1	Aftercare (After-Treatment) 11/2013
1	Critical Care (Surgical Intensive Care) 11/2009
1	Computer-Assisted Surgery (Image Guided Surgery) 05/2008
1	Secondary Prevention 01/2006
1	Endoscopes 03/2005
1	Neoadjuvant Therapy 12/2004
1	Anesthesia 11/2004
1	Reoperation 11/2003
1	Electrodes (Electrode) 02/2002